MANAGEMENT TEAM
John W. Simon
Chief Executive Officer
John Simon is a co-founder and Director of Acton Pharmaceuticals and also serves as its Chief Executive Officer. Prior to Acton, Mr. Simon spent 10 years at Sepracor Inc. where he served as Vice President, Respiratory Marketing. During his tenure, Mr. Simon launched and led Sepracor's largest revenue producing franchise with cumulative revenues of $2 billion. Prior to that, Mr. Simon was a marketing executive with Forest Laboratories from 1991 to 1997. John is a co-founder of Forge Therapeutics, LLC, a pre-clinical stage, small molecule biopharmaceutical company focused on cardiovascular disease. He has also served as an advisor to venture capital funds and early stage pharmaceutical companies. John received his B.A. degree from the University of Kentucky.
Daniel L. Kreisler
President and Chief Operating Officer
Daniel Kreisler is co-founder of Acton Pharmaceuticals, serves as its President and Chief Operating Officer and is a member of the Acton Board of Directors. Prior to Acton, Mr. Kreisler was a co-founder of JDS Pharmaceuticals, LLC, a specialty pharmaceutical company formed in 2004 where he held the position of Vice President, Business Development. In 2007, JDS was acquired by Noven Pharmaceuticals, Inc. for $125 million. Dan remained with Noven as Vice President, Business Development until mid-2009. Dan is a specialty pharmaceutical industry veteran with over 25 years of experience. Prior to co-founding Acton and JDS, Dan was co-founder of Krele Pharmaceuticals. Prior to that, Dan spent over 16 years at Forest Laboratories where he held positions in marketing management and business development. Dan holds a B.S. degree in Pharmacy from the University of Rhode Island.
Patrick Noland
Executive Vice President Technical Operations
Patrick is Acton's Executive Vice President Technical Operations and is responsible for all scientific, regulatory and quality aspects of development and commercial manufacturing. Mr. Noland has significant experience in aerosol delivery systems. Prior to joining Acton, Patrick was the Vice President Pharmaceutical Program Development for Analytical Bio-Chemistry Laboratories (ABC) where he provided comprehensive product development advice to ABC clients and enhanced their programs by utilizing database and modeling software and scientific methodologies. While at ABC, Pat collaborated on numerous IND and NDA submissions to the FDA on behalf of ABC's clients. Prior to ABC, Pat was at Sepracor and served as the Senior Director Quality Assurance & Director Quality Control. Pat contributed to CMC Sections for numerous Sepracor INDs and 5 Sepracor NDAs which included two respiratory inhalation products that were both approved within the initial PDUFA approval period. Pat has a MS and BS in Chemistry from the University of Missouri-Rolla.
